SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,957.27 -307.24
( -0.40%)

Global Indices

Nasdaq

53,569.16 -21.28
(-0.04%)

Dow Jones

7,731.77 -20.22
(-0.26%)

Hang Seng

66,147.06 -258.50
(-0.39%)

Nikkei 225

10,824.26 31.76
(0.29%)

Forex

USD-INR

95.48 0.22
(0.23%)

EUR-INR

111.24 0.16
(0.15%)

GBP-INR

129.74 0.04
(0.03%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gujarat Themis Biosyn Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506879

INE942C01045

26.4090145

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUJTHEM

91.89

4475.75

EPS(TTM)

Face Value()

Div & Yield %

4.47

0.16

Back

gujarat themis biosyn ltd

Gujarat Themis Biosyn standalone net profit rises 22.19% in the June 2026 quarter

Aug 07,2026

Net profit of Gujarat Themis Biosyn rose 22.19% to Rs 11.07 crore in the quarter ended June 2026 as against Rs 9.06 crore during the previous quarter ended June 2025. Sales rose 22.08% to Rs 43.79 crore in the quarter ended June 2026 as against Rs 35.87 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	43.79	35.87	22
OPM %	47.50	38.81	-
PBDT	19.14	14.15	35
PBT	15.17	12.12	25
NP	11.07	9.06	22

76,957.27 -307.24 ( -0.40%)

53,569.16 -21.28 (-0.04%)

7,731.77 -20.22 (-0.26%)

66,147.06 -258.50 (-0.39%)

10,824.26 31.76 (0.29%)

95.48 0.22 (0.23%)

111.24 0.16 (0.15%)

129.74 0.04 (0.03%)

0.60 0.00 (0.12%)